EDGAR Filing Documents for 0001485003-17-000148

Form 8-K - Current report:

SEC Accession No. 0001485003-17-000148

Filing Date

2017-12-15

Accepted

2017-12-15 16:22:14

Documents

Period of Report

2017-12-13

Items

Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing

Document Format Files

Seq	Description	Document	Type	Size
1	8-K	ebio-form8xknasdaqdeficien.htm	8-K	27391
	Complete submission text file	0001485003-17-000148.txt		28499

Mailing Address 245 FIRST STREET SUITE 1800 CAMBRIDGE MA 02142

Business Address 245 FIRST STREET SUITE 1800 CAMBRIDGE MA 02142 617-444-8550

Eleven Biotherapeutics, Inc. (Filer) CIK: 0001485003 (see all company filings)

IRS No.: 262025616 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36296 | Film No.: 171259220
SIC: 2834 Pharmaceutical Preparations